Compare DoorDash Inc (DASH) vs Smith & Nephew plc (SNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DoorDash Inc vs Smith & Nephew plc — how do they compare? DoorDash Inc trades at $188.64 (market cap $81.82B), while Smith & Nephew plc trades at $30.18 (market cap $12.40B). The key difference: DoorDash Inc is far larger — about 6.6× Smith & Nephew plc's market cap, and Smith & Nephew plc pays a 2.62% dividend while DoorDash Inc pays none. Which is the better fit depends on your goals.
| DASH | SNN | |
|---|---|---|
Market Cap | $81.82B | $12.40B |
Sector | Consumer Cyclical | Health |
52-Week High | $281.74 | $38.70 |
52-Week Low | $146.60 | $28.73 |
Enterprise Value | $79.58B | $15.17B |
Dividend Yield | — | 2.62% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DoorDash (DASH) trades at $189.57, down 1.17% on the day, with a bullish technical outlook supported by moving averages and key resistance near $200. The company reported strong revenue growth to $13.72B in 2025 and achieved profitability with a net income margin of 6.81%. Recent partnerships, such as with Hungry Howie's and Urban Outfitters, highlight ongoing expansion in digital commerce and loyalty programs.
The stock presents a growth opportunity with a consensus price target of $237.92, implying 25% upside, but faces risks from intense competition and high valuation multiples. Earnings momentum is mixed, with a recent beat in Q1 2026 but misses in prior quarters. Investors should weigh robust cash flow generation against elevated P/E and EV/EBITDA ratios for a balanced view.
SNN trades at $31.08, up 1.24% with a bullish technical signal. The company shows improving fundamentals with 2024 revenue of $5.81B and net income of $412M, while recent earnings beat expectations. Strong cash flow generation and new product launches in robotics and wound care support growth. Analyst consensus is mixed with 27% buy ratings but majority holds.
Outlook remains positive with projected revenue growth and margin expansion, though recent earnings misses and elevated valuation metrics pose risks. The stock's technical strength and fundamental recovery present opportunity, but investor caution is warranted given mixed analyst sentiment and competitive pressures in medical technology.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DoorDash Inc
Founded in 2013 and headquartered in San Francisco, DoorDash is an online food order demand aggregator. Consumers can use its app to order food on-demand for pickup or delivery from merchants mainly in the U.S. The firm provides a marketplace for the merchants to create a presence online, market their offerings, and meet demand by making the offerings available for pickup or delivery. The firm provides similar service to businesses in addition to restaurants, such as grocery, retail, pet supplies, and flowers. At the end of 2020, DoorDash had over 450,000 merchants, 20 million consumers, and over 1 million dashers on its platform. In 2020, the firm generated $24.7 billion in gross order volume (up 207% year over year) and $2.9 billion in revenue (up 226%).
Read more on DASH →About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →
